Repurposed Medicines and Cancer Research: Why the Ivermectin and Mebendazole Study Is Generating Interest
- Jul 28
- 4 min read

A newly published real world study exploring the use of ivermectin and mebendazole alongside cancer care is drawing significant attention among researchers, patients, and advocates of repurposed medicines.
Published in the journal Anticancer Research, the study followed 197 cancer patients with a variety of cancers including breast, prostate, colon, and lung cancer. Researchers investigated the effects of a compounded protocol using ivermectin and mebendazole, two long established medications with known safety histories and growing scientific interest for their potential anti cancer properties.
The study reported encouraging findings after approximately six months of treatment.



